Results 171 to 180 of about 7,679 (193)

Mepolizumab

Reactions Weekly, 2019
  +8 more sources

Mepolizumab

Reactions Weekly, 2021
  +5 more sources

Real-world Effectiveness of Mepolizumab in Severe Eosinophilic Asthma: A Systematic Review and Meta-analysis

Clinical Therapeutics, 2021
Jiangtao Lin
exaly  

Efficacy of mepolizumab in usual clinical practice and characteristics of responders

Respiratory Medicine, 2021
Francisco-Javier Gonzalez-Barcala, Luis Pérez-De-Llano, David Dacal-Rivas   +2 more
exaly  

Mepolizumab

Reactions Weekly, 2010
openaire   +1 more source

Mepolizumab

Drugs of the Future, 2007
null Revill, P., null Mealy, N.
openaire   +1 more source

Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis

European Journal of Internal Medicine, 2022
Isam Alobid, JOSÉ Hernández-Rodríguez, Maria C Cid   +2 more
exaly  

Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine

Journal of Allergy and Clinical Immunology: in Practice, 2021
Andrew Menzies-Gow, Njira Lugogo, Ian Pavord   +2 more
exaly  

Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study

Journal of Personalized Medicine, 2022
Eugenio De Corso, Veronica Seccia, Angela Rizzi   +2 more
exaly  

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma

World Allergy Organization Journal, 2022
Karl-Christian Bergmann, Torsten Zuberbier, Jean Bousquet   +2 more
exaly